Hereditary Angioedema
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
The purpose of this study is to evaluate the long-term safety and efficacy of donidalorsen in people with HAE and the effects of donidalorsen on the number of HAE attacks and their impact on quality of life (QoL).
Purpose of Study
The purpose of this study is to evaluate the long-term safety and efficacy of donidalorsen in people with HAE and the effects of donidalorsen on the number of HAE attacks and their impact on quality of life (QoL).
Eligibility
Age:
12 +Sex:
FemaleAccepting Volunteers:
YES
Conditions:
Hereditary Angioedema
Status:
RECRUITING
Phase:
Phase 3
Clinical Trials ID
NCT05392114
Read Detailed Summary:
Start Date / End Date:
07 2022 - 12 2026
Enrollment:
144